• Login
    View Item 
    •   UCUDIR Home
    • Research Papers and Publications
    • UCU School of Medicine
    • View Item
    •   UCUDIR Home
    • Research Papers and Publications
    • UCU School of Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.

    Thumbnail
    View/Open
    The final, definitive version of this paper has been published in the BMC Public Health, August/2009. https://doi.org/10.1186/1471-2458-9-290; published by BioMed Central Ltd. All rights reserved. (486.3Kb)
    Date
    2009-08-11
    Author
    Amuron, Barbara
    Namara, Geoffrey
    Birungi, Josephine
    Nabiryo, Christine
    Levin, Jonathan
    Grosskurth, Heiner
    Coutinho, Alex
    Jaffar, Shabbar
    Metadata
    Show full item record
    Abstract
    Background: In many HIV programmes in Africa, patients are assessed clinically and prepared for antiretroviral treatment over a period of 4–12 weeks. Mortality rates following initiation of ART are very high largely because patients present late with advanced disease. The rates of mortality and retention during the pre-treatment period are not well understood. We conducted an observational study to determine these rates. Methods: HIV-infected subjects presenting at The AIDS Support Clinic in Jinja, SE Uganda, were assessed for antiretroviral therapy (ART). Eligible subjects were given information and counselling in 3 visits done over 4–6 weeks in preparation for treatment. Those who did not complete screening were followed-up at home. Survival analysis was done using poisson regression. Results: 4321 HIV-infected subjects were screened of whom 2483 were eligible for ART on clinical or immunological grounds. Of these, 637 (26%) did not complete screening and did not start ART. Male sex and low CD4 count were associated independently with not completing screening. At follow-up at a median 351 days, 181 (28%) had died, 189 (30%) reported that they were on ART with a different provider, 158 (25%) were alive but said they were not on ART and 109 (17%) were lost to follow-up. Death rates (95% CI) per 100 person-years were 34 (22, 55) (n.18) within one month and 37 (29, 48) (n.33) within 3 months. 70/158 (44%) subjects seen at follow-up said they had not started ART because they could not afford transport. Conclusion: About a quarter of subjects eligible for ART did not complete screening and pretreatment mortality was very high even though patients in this setting were well informed. For many families, the high cost of transport is a major barrier preventing access to ART.
    Use this URI to cite this item:
    https://hdl.handle.net/20.500.11951/261
    Collections
    • UCU School of Medicine [158]

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV
     

     

    Browse

    All of UCUDIRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV